Latest Update: Impact of current COVID-19 situation has been considered in this report while making the analysis.
Global Digital Dose Inhaler Market by Type (Metered Dose Inhaler (MDI), Dry Powder Inhaler (DPI)), By Application (Hospital, Clinic) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030-report

Global Digital Dose Inhaler Market by Type (Metered Dose Inhaler (MDI), Dry Powder Inhaler (DPI)), By Application (Hospital, Clinic) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030

Report ID: 187090 3300 Medical Devices & Consumables 377 240 Pages 4.9 (31)
                                          

The global digital dose inhaler market is expected to grow at a CAGR of 5.5% during the forecast period, from 2021 to 2030. The growth of this market is attributed to the increasing prevalence of respiratory diseases and increasing awareness about the benefits of using digital dose inhalers. The global digital dose inhaler market is segmented on the basis of type, application, and region. On the basis of type, it is segmented into metered dose inhalers (MDI) and dry powder inhalers (DPI). On the basis of application, it is segmented into hospital and clinic. On the basis of region, it is segmented into North America, Latin America, Europe, Asia Pacific and Middle East & Africa.

Some Of The Growth Factors Of This Market:

  1. The increasing number of people suffering from asthma and other respiratory diseases is a major factor driving the growth of the digital dose inhaler market.
  2. The increasing awareness about the benefits of using digital dose inhalers over traditional inhalers is also a major factor driving the growth of this market.
  3. The growing preference for digital dose inhalers among healthcare professionals is another factor that will drive this market's growth in coming years.
  4. The rising demand for portable devices, which are easy to carry and use, will also fuel this market's growth in coming years as more people are becoming aware about their benefits over traditional devices such as nebulizers and metered-dose inhalers (MDIs).
  5. Increasing research on new technologies to improve the efficacy and safety profile of these devices will also fuel this market's growth in coming years.

Industry Growth Insights published a new data on “Digital Dose Inhaler Market”. The research report is titled “Digital Dose Inhaler Market research by Types (Metered Dose Inhaler (MDI), Dry Powder Inhaler (DPI)), By Applications (Hospital, Clinic), By Players/Companies Glenmark Pharmaceuticals Ltd., Novartis, Propeller Health, AstraZeneca Plc, Philips Respironics, Opko Health, Teva Pharmaceuticals”.

Scope Of The Report

Report Attributes

Report Details

Report Title

Digital Dose Inhaler Market Research Report

By Type

Metered Dose Inhaler (MDI), Dry Powder Inhaler (DPI)

By Application

Hospital, Clinic

By Companies

Glenmark Pharmaceuticals Ltd., Novartis, Propeller Health, AstraZeneca Plc, Philips Respironics, Opko Health, Teva Pharmaceuticals

Regions Covered

North America, Europe, APAC, Latin America, MEA

Base Year

2021

Historical Year

2019 to 2020 (Data from 2010 can be provided as per availability)

Forecast Year

2030

Number of Pages

240

Number of Tables & Figures

168

Customization Available

Yes, the report can be customized as per your need.


Global Digital Dose Inhaler Industry Outlook


Global Digital Dose Inhaler Market Report Segments:

The global Digital Dose Inhaler market is segmented on the basis of:

Types

Metered Dose Inhaler (MDI), Dry Powder Inhaler (DPI)

The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.

Applications

Hospital, Clinic

The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.

Some of the companies that are profiled in this report are:

  1. Glenmark Pharmaceuticals Ltd.
  2. Novartis
  3. Propeller Health
  4. AstraZeneca Plc
  5. Philips Respironics
  6. Opko Health
  7. Teva Pharmaceuticals

Global Digital Dose Inhaler Market Overview


Highlights of The Digital Dose Inhaler Market Report:

  1. The market structure and projections for the coming years.
  2. Drivers, restraints, opportunities, and current trends of market.
  3. Historical data and forecast.
  4. Estimations for the forecast period 2030.
  5. Developments and trends in the market.
  6. By Type:

    1. Metered Dose Inhaler (MDI)
    2. Dry Powder Inhaler (DPI)
  1. By Application:

    1. Hospital
    2. Clinic
  1. Market scenario by region, sub-region, and country.
  2. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
  3. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
  4. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Digital Dose Inhaler Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.

Regional Analysis

  • North America
  • Europe
  • Asia Pacific
  • Middle East & Africa
  • Latin America

Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.

The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.

How you may use our products:

  • Correctly Positioning New Products
  • Market Entry Strategies
  • Business Expansion Strategies
  • Consumer Insights
  • Understanding Competition Scenario
  • Product & Brand Management
  • Channel & Customer Management
  • Identifying Appropriate Advertising Appeals

Global Digital Dose Inhaler Market Statistics

8 Reasons to Buy This Report

  1. Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
  2. Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
  3. Implemented Robust Methodology to Prepare the Report
  4. Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
  5. Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
  6. Provides Information About the Top-winning Strategies Implemented by Industry Players.
  7. In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
  8. Customization of the Report Available

Frequently Asked Questions?


A digital dose inhaler (DDI) is a type of asthma medication that uses electronic sensors to measure the amount of medicine delivered to the lungs. This helps ensure that patients receive the correct dose, and avoids potential side effects caused by incorrect dosing.

Some of the key players operating in the digital dose inhaler market are Glenmark Pharmaceuticals Ltd., Novartis, Propeller Health, AstraZeneca Plc, Philips Respironics, Opko Health, Teva Pharmaceuticals.

The digital dose inhaler market is expected to grow at a compound annual growth rate of 5.5%.

                                            
1. Executive Summary

2. Assumptions and Acronyms Used

3. Research Methodology

4. Digital Dose Inhaler Market Overview
   4.1. Introduction
      4.1.1. Market Taxonomy
      4.1.2. Market Definition
   4.2. Macro-Economic Factors
      4.2.1. Industry Outlook
   4.3. Digital Dose Inhaler Market Dynamics
      4.3.1. Market Drivers
      4.3.2. Market Restraints
      4.3.3. Opportunity
      4.3.4. Market Trends
   4.4. Digital Dose Inhaler Market - Supply Chain
   4.5. Global Digital Dose Inhaler Market Forecast
      4.5.1. Digital Dose Inhaler Market Size (US$ Mn) and Y-o-Y Growth
      4.5.2. Digital Dose Inhaler Market Size (000’ Units) and Y-o-Y Growth
      4.5.3. Digital Dose Inhaler Market Absolute $ Opportunity

5. Global Digital Dose Inhaler Market Analysis and Forecast by Type
   5.1. Market Trends
   5.2. Introduction
      5.2.1. Basis Point Share (BPS) Analysis by Type
      5.2.2. Y-o-Y Growth Projections by Type
   5.3. Digital Dose Inhaler Market Size and Volume Forecast by Type
      5.3.1. Metered Dose Inhaler (MDI)
      5.3.2. Dry Powder Inhaler (DPI)
   5.4. Absolute $ Opportunity Assessment by Type
   5.5. Market Attractiveness/Growth Potential Analysis by Type

6. Global Digital Dose Inhaler Market Analysis and Forecast by Application
   6.1. Market Trends
   6.2. Introduction
      6.2.1. Basis Point Share (BPS) Analysis by Application
      6.2.2. Y-o-Y Growth Projections by Application
   6.3. Digital Dose Inhaler Market Size and Volume Forecast by Application
      6.3.1. Hospital
      6.3.2. Clinic
   6.4. Absolute $ Opportunity Assessment by Application
   6.5. Market Attractiveness/Growth Potential Analysis by Application

7. Global Digital Dose Inhaler Market Analysis and Forecast by Sales Channel
   7.1. Market Trends
   7.2. Introduction
      7.2.1. Basis Point Share (BPS) Analysis by Sales Channel 
      7.2.2. Y-o-Y Growth Projections by Sales Channel
   7.3. Digital Dose Inhaler Market Size and Volume Forecast by Sales Channel 
      7.3.1. Manufacturer/Distributor/Service Provider
      7.3.2. Aftermarket
   7.4. Absolute $ Opportunity Assessment by Sales Channel
   7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel

8. Global Digital Dose Inhaler Market Analysis and Forecast by Region
   8.1. Market Trends
   8.2. Introduction
      8.2.1. Basis Point Share (BPS) Analysis by Region
      8.2.2. Y-o-Y Growth Projections by Region
   8.3. Digital Dose Inhaler Market Size and Volume Forecast by Region
      8.3.1. North America
      8.3.2. Latin America
      8.3.3. Europe
      8.3.4. Asia Pacific
      8.3.5. Middle East and Africa (MEA)
   8.4. Absolute $ Opportunity Assessment by Region
   8.5. Market Attractiveness/Growth Potential Analysis by Region
   8.6. Global Digital Dose Inhaler Demand Share Forecast, 2019-2026

9. North America Digital Dose Inhaler Market Analysis and Forecast
   9.1. Introduction
      9.1.1. Basis Point Share (BPS) Analysis by Country
      9.1.2. Y-o-Y Growth Projections by Country
   9.2. North America Digital Dose Inhaler Market Size and Volume Forecast by Country
      9.2.1. U.S.
      9.2.2. Canada
   9.3. Absolute $ Opportunity Assessment by Country
   9.4. North America Digital Dose Inhaler Market Size and Volume Forecast by Application
      9.4.1. Hospital
      9.4.2. Clinic
   9.5. Basis Point Share (BPS) Analysis by Application
   9.6. Y-o-Y Growth Projections by Application
   9.7. North America Digital Dose Inhaler Market Size and Volume Forecast by Type
      9.7.1. Metered Dose Inhaler (MDI)
      9.7.2. Dry Powder Inhaler (DPI)
   9.8. Basis Point Share (BPS) Analysis by Type
   9.9. Y-o-Y Growth Projections by Type
   9.10. Market Attractiveness/Growth Potential Analysis
      9.10.1. By Country
      9.10.2. By Product Type
      9.10.3. By Application
      9.10.4. By Sales Channel
   9.11. North America Digital Dose Inhaler Demand Share Forecast, 2019-2026

10. Latin America Digital Dose Inhaler Market Analysis and Forecast
   10.1. Introduction
      10.1.1. Basis Point Share (BPS) Analysis by Country
      10.1.2. Y-o-Y Growth Projections by Country
      10.1.3. Latin America Average Pricing Analysis
   10.2. Latin America Digital Dose Inhaler Market Size and Volume Forecast by Country
      10.2.1. Brazil
      10.2.2. Mexico
      10.2.3. Rest of Latin America
   10.3. Absolute $ Opportunity Assessment by Country
   10.4. Latin America Digital Dose Inhaler Market Size and Volume Forecast by Application
      10.4.1. Hospital
      10.4.2. Clinic
   10.5. Basis Point Share (BPS) Analysis by Application
   10.6. Y-o-Y Growth Projections by Application
   10.7. Latin America Digital Dose Inhaler Market Size and Volume Forecast by Type
      10.7.1. Metered Dose Inhaler (MDI)
      10.7.2. Dry Powder Inhaler (DPI)
   10.8. Basis Point Share (BPS) Analysis by Type
   10.9. Y-o-Y Growth Projections by Type
   10.10. Market Attractiveness/Growth Potential Analysis
      10.10.1. By Country
      10.10.2. By Product Type
      10.10.3. By Application
      10.10.4. By Sales Channel
   10.11. Latin America Digital Dose Inhaler Demand Share Forecast, 2019-2026

11. Europe Digital Dose Inhaler Market Analysis and Forecast
   11.1. Introduction
      11.1.1. Basis Point Share (BPS) Analysis by Country
      11.1.2. Y-o-Y Growth Projections by Country
      11.1.3. Europe Average Pricing Analysis
   11.2. Europe Digital Dose Inhaler Market Size and Volume Forecast by Country
      11.2.1. Germany
      11.2.2. France
      11.2.3. Italy
      11.2.4. U.K.
      11.2.5. Spain
      11.2.6. Russia
      11.2.7. Rest of Europe
   11.3. Absolute $ Opportunity Assessment by Country
   11.4. Europe Digital Dose Inhaler Market Size and Volume Forecast by Application
      11.4.1. Hospital
      11.4.2. Clinic
   11.5. Basis Point Share (BPS) Analysis by Application
   11.6. Y-o-Y Growth Projections by Application
   11.7. Europe Digital Dose Inhaler Market Size and Volume Forecast by Type
      11.7.1. Metered Dose Inhaler (MDI)
      11.7.2. Dry Powder Inhaler (DPI)
   11.8. Basis Point Share (BPS) Analysis by Type
   11.9. Y-o-Y Growth Projections by Type
   11.10. Market Attractiveness/Growth Potential Analysis
      11.10.1. By Country
      11.10.2. By Product Type
      11.10.3. By Application
      11.10.4. By Sales Channel
   11.11. Europe Digital Dose Inhaler Demand Share, 2019-2026

12. Asia Pacific Digital Dose Inhaler Market Analysis and Forecast
   12.1. Introduction
      12.1.1. Basis Point Share (BPS) Analysis by Country
      12.1.2. Y-o-Y Growth Projections by Country
      12.1.3. Asia Pacific Average Pricing Analysis
   12.2. Asia Pacific Digital Dose Inhaler Market Size and Volume Forecast by Country
      12.2.1. China
      12.2.2. Japan
      12.2.3. South Korea
      12.2.4. India
      12.2.5. Australia
      12.2.6. Rest of Asia Pacific (APAC)
   12.3. Absolute $ Opportunity Assessment by Country
   12.4. Asia Pacific Digital Dose Inhaler Market Size and Volume Forecast by Application
      12.4.1. Hospital
      12.4.2. Clinic
   12.5. Basis Point Share (BPS) Analysis by Application
   12.6. Y-o-Y Growth Projections by Application
   12.7. Asia Pacific Digital Dose Inhaler Market Size and Volume Forecast by Type
      12.7.1. Metered Dose Inhaler (MDI)
      12.7.2. Dry Powder Inhaler (DPI)
   12.8. Basis Point Share (BPS) Analysis by Type
   12.9. Y-o-Y Growth Projections by Type
   12.10. Market Attractiveness/Growth Potential Analysis
      12.10.1. By Country
      12.10.2. By Product Type
      12.10.3. By Application
      12.10.4. By Sales Channel
   12.11. Asia Pacific Digital Dose Inhaler Demand Share, 2019-2026

13. Middle East & Africa Digital Dose Inhaler Market Analysis and Forecast
   13.1. Introduction
      13.1.1. Basis Point Share (BPS) Analysis by Country
      13.1.2. Y-o-Y Growth Projections by Country
      13.1.3. Asia Pacific Average Pricing Analysis
   13.2. Middle East & Africa Digital Dose Inhaler Market Size and Volume Forecast by Country
      13.2.1. Saudi Arabia
      13.2.2. South Africa
      13.2.3. UAE
      13.2.4. Rest of Middle East & Africa (MEA)
   13.3. Absolute $ Opportunity Assessment by Country
   13.4. Middle East & Africa Digital Dose Inhaler Market Size and Volume Forecast by Application
      13.4.1. Hospital
      13.4.2. Clinic
   13.5. Basis Point Share (BPS) Analysis by Application
   13.6. Y-o-Y Growth Projections by Application
   13.7. Middle East & Africa Digital Dose Inhaler Market Size and Volume Forecast by Type
      13.7.1. Metered Dose Inhaler (MDI)
      13.7.2. Dry Powder Inhaler (DPI)
   13.8. Basis Point Share (BPS) Analysis by Type
   13.9. Y-o-Y Growth Projections by Type
   13.10. Market Attractiveness/Growth Potential Analysis
      13.10.1. By Country
      13.10.2. By Product Type
      13.10.3. By Application
      13.10.4. By Sales Channel
   13.11. Middle East & Africa Digital Dose Inhaler Demand Share, 2019-2026

14. Competition Landscape
   14.1. Global Digital Dose Inhaler Market: Market Share Analysis
   14.2. Digital Dose Inhaler Distributors and Customers
   14.3. Digital Dose Inhaler Market: Competitive Dashboard
   14.4. Company Profiles (Details – Overview, Financials, Developments, Strategy) 
      14.4.1. Glenmark Pharmaceuticals Ltd.
         14.4.1.1. Overview
         14.4.1.2. Financials
         14.4.1.3. Developments
         14.4.1.4. Strategic Outlook
      14.4.2. Novartis
         14.4.2.1. Overview
         14.4.2.2. Financials
         14.4.2.3. Developments
         14.4.2.4. Strategic Outlook
      14.4.3. Propeller Health
         14.4.3.1. Overview
         14.4.3.2. Financials
         14.4.3.3. Developments
         14.4.3.4. Strategic Outlook
      14.4.4. AstraZeneca Plc
         14.4.4.1. Overview
         14.4.4.2. Financials
         14.4.4.3. Developments
         14.4.4.4. Strategic Outlook
      14.4.5. Philips Respironics
         14.4.5.1. Overview
         14.4.5.2. Financials
         14.4.5.3. Developments
         14.4.5.4. Strategic Outlook
      14.4.6. Opko Health
         14.4.6.1. Overview
         14.4.6.2. Financials
         14.4.6.3. Developments
         14.4.6.4. Strategic Outlook
      14.4.7. Teva Pharmaceuticals
         14.4.7.1. Overview
         14.4.7.2. Financials
         14.4.7.3. Developments
         14.4.7.4. Strategic Outlook
      14.4.8. COMPANY8
         14.4.8.1. Overview
         14.4.8.2. Financials
         14.4.8.3. Developments
         14.4.8.4. Strategic Outlook
      14.4.9. COMPANY9
         14.4.9.1. Overview
         14.4.9.2. Financials
         14.4.9.3. Developments
         14.4.9.4. Strategic Outlook
      14.4.10. COMPANY 10
         14.4.10.1. Overview
         14.4.10.2. Financials
         14.4.10.3. Developments
         14.4.10.4. Strategic Outlook
      14.4.11. COMPANY 11
         14.4.11.1. Overview
         14.4.11.2. Financials
         14.4.11.3. Developments
         14.4.11.4. Strategic Outlook
      14.4.12. COMPANY 12
         14.4.12.1. Overview
         14.4.12.2. Financials
         14.4.12.3. Developments
         14.4.12.4. Strategic Outlook
      14.4.13. COMPANY 13
         14.4.13.1. Overview
         14.4.13.2. Financials
         14.4.13.3. Developments
         14.4.13.4. Strategic Outlook
      14.4.14. COMPANY 14
         14.4.14.1. Overview
         14.4.14.2. Financials
         14.4.14.3. Developments
         14.4.14.4. Strategic Outlook
      14.4.15. COMPANY 15
         14.4.15.1. Overview
         14.4.15.2. Financials
         14.4.15.3. Developments
         14.4.15.4. Strategic Outlook
      14.4.16. COMPANY 16
         14.4.16.1. Overview
         14.4.16.2. Financials
         14.4.16.3. Developments
         14.4.16.4. Strategic Outlook
      14.4.17. COMPANY 17
         14.4.17.1. Overview
         14.4.17.2. Financials
         14.4.17.3. Developments
         14.4.17.4. Strategic Outlook
      14.4.18. COMPANY 18
         14.4.18.1. Overview
         14.4.18.2. Financials
         14.4.18.3. Developments
         14.4.18.4. Strategic Outlook
      14.4.19. COMPANY 19
         14.4.19.1. Overview
         14.4.19.2. Financials
         14.4.19.3. Developments
         14.4.19.4. Strategic Outlook
      14.4.20. COMPANY 20
         14.4.20.1. Overview
         14.4.20.2. Financials
         14.4.20.3. Developments
         14.4.20.4. Strategic Outlook

Our Trusted Clients

Contact Us